US FDA Approved Johnson & Johnson’s Blood Cancer Therapy
The US Food and Drug Administration (FDA) has approved Johnson & Johnson’s new therapy to treat a type of multiple myeloma, and the therapy has given another option of treatment to patients suffering with incurable blood cancer. According to Johnson & Johnson, teclistamab therapy, which is branded as Tecvayli, is approved to treat adults with […]
Continue Reading